3 hours Altimmune, Inc. (NASDAQ:ALT) Given Average Rating of “Moderate Buy” by Analysts MarketBeat
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold rating, four have ass…